Remove Ablation Remove Defibrillator Remove Tachycardia
article thumbnail

Exploring Potential New Treatment for Ventricular Tachycardia

DAIC

Cingolani, director of Cardiogenetics and Preclinical Research in the Department of Cardiology in the Smidt Heart Institute at Cedars-Sinai, is exploring new ways to help patients with ventricular tachycardia (VT), a recurring, abnormally fast and irregular heartbeat that starts in the lower chambers, or ventricles, of the heart.

article thumbnail

Preventive ablation of ventricular tachycardia avoids shocks and hospitalization, finds clinical trial

Medical Xpress - Cardiology

The first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular arrhythmias (VAs) reduces the risk of appropriate implantable cardioverter-defibrillator (ICD) therapy and unplanned hospitalization in patients with no (..)

article thumbnail

Ventricular Tachycardia Management

All About Cardiovascular System and Disorders

Ventricular tachycardia is a potentially life threatening cardiac arrhythmia. On the ECG, ventricular tachycardia can be defined as three or more ventricular ectopic beats occurring in a sequence at a rate more than 100 per minute. Another rare form of ventricular tachycardia is bidirectional ventricular tachycardia.

article thumbnail

PO-06-070 RECURRENT VENTRICULAR TACHYCARDIA POST CARDIAC RADIOABLATION: INSIGHTS FROM REPEAT VT ABLATION POST RA.

HeartRhythm

Patients suffering recurrent Ventricular Tachycardia (VT) despite antiarrhythmic drugs, defibrillator and ablation remain at significant risk of morbidity and mortality. Although cardiac radioablation (RA) has demonstrated promise, results are heterogenous.

article thumbnail

Intra-Pericardial Position of an Extra-Vascular Implantable Cardioverter-Defibrillator Lead

HeartRhythm

An 18-year-old male with arrhythmogenic cardiomyopathy was referred for catheter ablation of ventricular tachycardia after experiencing appropriate implantable cardioverter-defibrillator (ICD) shock. Six months prior, he had undergone uncomplicated implantation of an extravascular ICD (EV-ICD) [1].

article thumbnail

PO-01-148 COMPASSIONATE USE OF STEREOTACTIC RADIOABLATION FOR VENTRICULAR TACHYCARDIA: SAFETY AND EFFICACY AT ONE YEAR

HeartRhythm

Patients suffering recurrent Ventricular Tachycardia (VT) despite antiarrhythmic drugs (AAD), defibrillator (ICD) and catheter ablation (CA) remain at significant risk of morbidity and mortality.

article thumbnail

PO-01-123 RECURRENT VT IS SLOWER IN PATIENTS TREATED WITH ESCALATED ANTIARRHYTHMIC DRUG THERAPY: INSIGHTS FROM THE VANISH TRIAL

HeartRhythm

Optimization of implantable cardioverter defibrillator (ICD) programming is essential to minimize inappropriate shocks, and to ensure appropriate ICD therapies are delivered for slower ventricular tachycardia (VT).